IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$476.27 USD
+2.99 (0.63%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $476.27 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$476.27 USD
+2.99 (0.63%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $476.27 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Zacks News
NEOGEN (NEOG) Enhances Aquaculture Genotyping With New Pact
by Zacks Equity Research
NEOGEN (NEOG) together with CAT can enable members of the aquaculture sector to make more informed breeding decisions.
LabCorp (LH), Molecular Loop Team Up for COVID-19 Test Research
by Zacks Equity Research
The SARS-CoV-2 Research Sequencing Panel will help LabCorp (LH) sequence thousands of complete coronavirus genomes each week from positive patient samples.
Hologic (HOLX) Gets European Nod for Aptima CMV Quant Assay
by Zacks Equity Research
Hologic's (HOLX) Aptima CMV Quant assay is intended to help in the diagnosis and management of solid-organ transplant patients and hematopoietic stem cell transplant patients.
Quest Diagnostics (DGX) Unveils Corporate Responsibility Report
by Zacks Equity Research
Per Quest Diagnostics' (DGX) 2020 Corporate Responsibility Report, it has expanded COVID-19 capacity throughout the year, performing 30 million COVID-19 molecular tests and serology tests.
Medtronic (MDT) Gets Expanded FDA Nod for Cryoablation Catheters
by Zacks Equity Research
Medtronic's (MDT) Cardiac Cryoablation Catheters offer safe and effective substitute to antiarrhythmic drug therapy for the prevention of atrial arrythmia recurrence.
Illumina's (ILMN) NovaSeq Adoption Aids, Margin Woe Stays
by Zacks Equity Research
Illumina (ILMN) derives benefits from the cascading effect of the ACOG guidance on increasing coverage of NIPT for all pregnancies.
Hologic (HOLX) to Beat Post-COVID Woes With Mobidiag Buyout
by Zacks Equity Research
Hologic (HOLX) management believes that Mobidiag has created a differentiated platform that deals with many of the historical challenges faced in multiplexed point-of-care molecular testing.
Abbott's (ABT) Base Business Recovers, Lowered View Concerns
by Zacks Equity Research
According to Abbott (ABT), significant reductions in the number of COVID-19 cases in the United States and other major developed countries to hamper demand for COVID-19 testing in 2021.
Thermo Fisher's (TMO) New Launch Boosts Preclinical Development
by Zacks Equity Research
Thermo Fisher's (TMO) enhanced Quick to Clinic solution provides balance of speed and quality to accelerate and advance DNA to Investigational New Drug in as less as 13 months.
Bruker (BRKR) Updates 2021 Outlook, Issues Medium-Term View
by Zacks Equity Research
Bruker (BRKR) updates 2021 financial guidance encouraged by solid business growth and high-growth opportunities.
Walgreens' (WBA) Retail Products Now Available on Uber Eats
by Zacks Equity Research
Walgreens (WBA) now offers on-demand product delivery through an expanded collaboration with Uber.
Phirbo (PAHC) Nutritional Specialties Grow, Vaccine Sales Dip
by Zacks Equity Research
Currently, Phirbo (PAHC) is focused on expanding its footprint in the poultry, swine and cattle industries, in both domestic and international markets.
ResMed (RMD) Rallies as Philips Falters on Mass Product Recall
by Zacks Equity Research
The full U.S. launch of ResMed (RMD) AirSense 11 is expected any time in 2021, which might receive bigger market acceptance capitalizing on its current peer position.
Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now
by Zacks Equity Research
Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and bullish 2021 outlook.
LabCorp (LH) Boosts Precision Oncology With INSIGHT NGS Launch
by Zacks Equity Research
LabCorp (LH) enables evidence-based, personalized treatment suggestions based on the genomic profiling of a patient's solid tumor with the launch of new test.
Medtronic (MDT) Progresses in SCS With FDA Nod for Vanta
by Zacks Equity Research
Vanta utilizes Medtronic's (MDT) proprietary AdaptiveStim technology for personalized pain relief.
Teleflex (TFX) Procedure Volume Recovers as Pandemic Subsides
by Zacks Equity Research
The UroLift System remains a major contributor to Teleflex (TFX) revenues.
Edwards Lifesciences (EW) at a 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about Edwards Lifesciences (EW) on its promising Surgical Structural Heart business and bullish 2021 guidance.
Henry Schein (HSIC) Enhances Dental Practices With New Deal
by Zacks Equity Research
Henry Schein's (HSIC) acquisition of majority stake in eAssist will enable it to offer best quality solutions to help dental practices operate efficiently and profitably.
Tandem (TNDM) Presents Data Backing Control-IQ Technology
by Zacks Equity Research
Data presented at the ATTD conference demonstrates Tandem Diabetes Care's (TNDM) Control-IQ technology's ability to make a positive and sustained impact on diabetes care.
Hologic (HOLX) Acessa Procedure Now Covered by Cigna Insurance
by Zacks Equity Research
Hologic's (HOLX) Acessa procedure new coverage will further validate Laparoscopic Radiofrequency Ablation as a standard of care for uterine fibroids.
LabCorp's (LH) Pixel Home Collection Kit Now in WBA Stores
by Zacks Equity Research
According to LabCorp (LH), the on-demand delivery option is useful for individuals showing symptoms of COVID-19 infection who want to be tested without potentially infecting others.
CVS Health (CVS) Deploys Time-Delay Safes in Georgia Pharmacies
by Zacks Equity Research
CVS Health's (CVS) time-delay safes are anticipated to help reduce robbery incidents.
Thermo Fisher (TMO) End Markets Rebound as COVID-19 Cases Drop
by Zacks Equity Research
In academic and government end markets, Thermo Fisher (TMO) grows on robust customer activity globally.
Medtronic (MDT) Progresses in Neuromodulation on New FDA Nod
by Zacks Equity Research
Medtronic's (MDT) SenSight claims to deliver patient-specific DBS therapy for the treatment of symptoms associated with Parkinson's, dystonia and essential tremor and medically refractory epilepsy.